AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2017

Mar 17, 2017

Director's Dealing

Opens in your device viewer

Issuer: CYTORI THERAPEUTICS, INC. (CTYX)
CIK: 0001095981
Period of Report: 2017-03-08

Reporting Person: HEDRICK MARC H (Director, President and CEO)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-08	Incentive Stock Option (right to buy)	$1.55	A	96350	Acquired	2027-03-08	Common Stock (96350)	Direct

F1: Option shares shall vest and become exercisable over four (4) years in forty-eight consecutive monthly installments.